Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  SkyePharma PLC    SKP   GB00B3BFNB64

SKYEPHARMA PLC (SKP)

11
Delayed Quote. Delayed London Stock Exchange - 03/27 12:35:13 pm
310.75 GBp   -1.43%
03/25 SKYEPHARMA : mixed results
03/24 SKYEPHARMA : Confident In Prospects Despite Wider Loss In 2014
02/13 SKYEPHARMA : To Repay Remainder Of CRC Finance Facility Early
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
03/23/2015 03/24/2015 03/25/2015 03/26/2015 03/27/2015 Date
324(c) 321.25(c) 320(c) 315.25(c) 310.75(c) Last
1 036 615 409 743 135 701 148 979 28 979 Volume
+0.31% -0.85% -0.39% -1.48% -1.43% Change
More quotes
Financials ( GBP)
Sales 2015 97,0 M
EBIT 2015 25,9 M
Net income 2015 21,0 M
Finance 2015 28,8 M
Yield 2015 -
Sales 2016 102 M
EBIT 2016 25,4 M
Net income 2016 22,1 M
Finance 2016 43,9 M
Yield 2016 -
PER 2015 16,18
PER 2016 15,23
EV / Sales 2015 3,06x
EV / Sales 2016 2,77x
Capitalization 326 M
More Financials
Company
SkyePharma Plc is a UK based pharmaceutical company.It engages in the research and development, licensing, manufacturing, marketing and distribution of prescription pharmaceutical products.The company approves products in the areas of oral, inhalation and topical delivery.SkyePharma was founded by... 
Sector
Pharmaceuticals
Calendar
08/20Earnings Release
More about the company
Surperformance© ratings of SkyePharma PLC
Trading Rating : Investor Rating :
More Ratings
Latest news on SKYEPHARMA PLC
03/25 SKYEPHARMA : mixed results
03/24 SKYEPHARMA : Confident In Prospects Despite Wider Loss In 2014
02/13 SKYEPHARMA : To Repay Remainder Of CRC Finance Facility Early
01/12DJSkyepharma Shares Fall as Royalties from GSK Lag
01/12 SKYEPHARMA : To Meet Expectations But Glaxo Royalties Slower
2014 SKYEPHARMA : Launches Flutiform In Spain, Italy; New Product In Japan
2014 SKYEPHARMA : Says Sales Momentum Has Continued Since August
2014 SKYEPHARMA : Partner Announces Phase III Flutiform Study Results
More news
Sector news : Pharmaceuticals - NEC
03/27 HOSPIRA : first biosimilar could be its first to gain FDA approval
03/27 VALEANT PHARMACEUTICALS INTL : S&P Dow Jones Indices Announces Changes to the S&..
03/27DJGilead Sciences CEO's Pay Rose 23% Last Year
More sector news : Pharmaceuticals - NEC


Comments 
Advertisement
Chart SKYEPHARMA PLC
Duration : Period :
SkyePharma PLC Technical Analysis Chart | SKP | GB00B3BFNB64 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF